aidsmap news story
DoxyPEP in Seattle is linked to a halving of syphilis diagnoses overall and a reduction of cases by a third in transgender people. Despite very low uptake, women also experienced a significant drop in syphilis cases, likely partly explained by reduced syphilis transmission within the communities where doxyPEP is being used.
In the study published in the journal of Clinical Infectious Diseases, Dr Timothy Menza and colleagues from Public Health – Seattle and King County and the University of Washington add more population-level evidence suggesting that the use of doxyPEP can significantly lower syphilis diagnoses. They estimate that doxyPEP use was associated with 52% fewer syphilis cases overall, with reductions of 53% in men, 47% in women and 33% in transgender and non-binary people.
Read the full news story here.
Source : aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.